The commonly-used epilepsy drug, valproic acid (VPA), can have a highly beneficial effect on some babies born with spinal muscular atrophy (SMA), the number one genetic killer during early infancy. But in about two-thirds ...
Jun 23, 2012
0
0
(HealthDay) -- For patients with migraines, 20.9 percent of incident mild headaches can be explained by temperature changes; and most red-wine-sensitive migraineurs do not experience migraine every time they drink red wine, ...
Jun 20, 2012
0
0
(HealthDay) -- Behavioral treatments can prevent migraines in some patients, but many migraine specialists aren't aware of this and don't refer people for therapy, a new study indicates.
Jun 20, 2012
1
0
An international research group has identified four new gene loci predisposing people to the most common subtype of migraine, migraine without aura. About two-thirds of migraine sufferers belong to this group. The study will ...
Jun 10, 2012
0
0
New hope has arrived for migraine sufferers following a Griffith University study with the people of Norfolk Island.
Jun 4, 2012
0
1
(HealthDay) -- Treatment with sumatriptan and naproxen sodium (suma/nap) is well tolerated and effective in reducing migraine pain in adolescents, according to a study published online May 14 in Pediatrics.
May 15, 2012
0
0
Migraine pain sits at the upper end of the typical pain scale – an angry-red section often labeled "severe." At this intensity, pain is debilitating. Yet many sufferers do not get relief from – or cannot tolerate ...
May 1, 2012
0
0
Although botulinum toxin A ("Botox") injections are U.S. Food and Drug Administration approved for preventive treatment for chronic migraines, a review and analysis of previous studies finds a small to modest benefit for ...
Apr 24, 2012
0
2
Research shows that many treatments can help prevent migraine in certain people, yet few people with migraine who are candidates for these preventive treatments actually use them, according to new guidelines issued by the ...
Apr 23, 2012
0
0
Chronic migraine sufferers saw significant pain relief after four weeks of electrical brain stimulation in the part of the brain responsible for voluntary movement, the motor cortex, according to a new study.
Apr 20, 2012
0
0
